Pearle Vision announces 2013 expansion

Article

Ernie Bowling, OD, reports on retail outlet Pearle Vision’s plans for expansion this year, during the 90th annual SECO International meeting in Atlanta.

Chief Optometric Editor Ernie Bowling, OD, reports on retail outlet Pearle Vision’s plans for expansion this year, during the 90th annual SECO International meeting in Atlanta:

Pearle Vision, North America’s largest licensed optical brand, outlined its 2013 expansion plans. Tammy Reaves, vice president of licensing and development for Pearle Vision, said the company intends to convert 35 corporate locations to franchise opportunities in addition to building up to 10 new stores this year.

The company has identified Florida, Ohio, and Michigan as the first markets for its re-licensing efforts. Specifically in Florida, Pearle is looking to convert corporate locations in Miami, West Palm Beach, Naples, Jacksonville, and Orlando to licensed locations. In Ohio, the company intends to convert locations in Cleveland, Columbus, and Cincinnati. Michigan centers in Detroit, Grand Rapids, Lansing, and Flint are available.

“We are looking for doctors who desire to work with a proven brand and provide superior eyecare and patient service,” Reaves said.

Pearle Vision is built around a doctor-centered business model and is owned by eyewear manufacturer and distributor Luxottica.

Recent Videos
Danielle Crull, ABOM, and Truffles of A Child's Eyes talk pediatric eye health and initiatives
Danielle Crull and Truffles the Kitty talk eye care initiatives for pediatric patients
World Sight Day 2024
Danielle Crull, ABOM, and Truffles of A Child's Eyes talk pediatric eye health and initiatives
Dr. Analisa Arosemena discusses glaucoma at EyeCon 2024
Pediatric optometrist Dr. Magdela Stec speaks about myopia management at EyeCon 2024
Dr. Mark Dunbar chats about his EyeCon 2024 presentation about diabetic eye care
Dr. Khanh Hoang at EyeCon 2024 receiving the Visionary in Eye Care Award
Dr Adam Wenick at EyeCon 2024
David Chin Yee, MD, at EyeCon 2024
© 2024 MJH Life Sciences

All rights reserved.